Genetic data suggest that the yeast cell cycle control gene CDC25 is an upstream regulator of R4S2. We have been able to show for the first time that the guanine nucleotide exchange proteins Cdc25 and Sdc25 from Saccharomyces cerevisiae bind directly to their targets Rasl and Ras2 in vivo. Using the characteristics of the yeast Acel transcriptional activator to probe for protein-protein interaction, we found that the CDC25 gene product binds specifically to wild-type Ras2 but not to the mutated Ras2vaIl9 and Ras2AvaIl9 proteins. The binding properties of Cdc25 to Ras2 were strongly diminished in yeast cells expressing an inactive Iral protein, which normally acts as a negative regulator of Ras activity. On the basis of these data, we propose that the ability of Cdc25 to interact with Ras2 proteins is strongly dependent on the activation state of Ras2. Cdc25 binds predominantly to the catalytically inactive GDP-bound form of Ras2, whereas a conformational change of Ras2 to its activated GTP-bound state results in its loss of binding affinity to Cdc25.
The Ras proteins of Saccharomyces cerevisiae belong to a large family of GTP-binding proteins. In yeast cells, Ras exhibits a crucial function in the nutrient signal transduction pathway, which indicates the availability of nutrients to cellular processes. Ras accomplishes its biological function through a cycle of GDP-GTP exchange and subsequent GTP hydrolysis (3, 26) (Fig. 1) . It stimulates adenylate cyclase (AC) in a GTP-dependent manner via the cyclase-associated protein Capl (also called Srv2) (17, 20, 25) , which finally results in the formation of the second messenger cyclic AMP (cAMP). The activation state of Ras is controlled by two classes of regulatory proteins encoded by the genes IRA1! IRA2 and CDC25/SDC25, respectively. The Iral or Ira2 protein can convert Ras to the catalytically inactive, GDPbound state (54, 56) by stimulation of the intrinsic GTPase activity of Ras (53) . It has been shown that the reverse reaction, a GDP-to-GTP exchange, is catalyzed by the CDC25 and SDC25 gene products (13, 32) (Fig. 1) . The CDC25 gene was originally identified as a temperaturesensitive mutation leading to an arrest of mitotic cell growth in Gl, which is accomplished by an altered intracellular level of cAMP at the restrictive temperature (46) . Genetic data indicate that the CDC25 gene product acts as a regulatory element upstream of Ras (4) because the dominant activating RAS2Val-l9 and RAS2A mutants are able to bypass the growth arrest of the conditionally lethal cdc25-1 mutation as well as lethal cdc25 disruptions (37, 47) . Recently, Powers et al. (45) described the isolation of two dominant lethal RAS mutations (RAS2Ja-22 and RAS2Pro-25). It has been proposed that the encoded mutant Ras proteins form a strong complex with the product of the CDC25 gene.
To further investigate the relationship between Cdc25 and Ras proteins, we established a system in S. cerevisiae that makes use of fusion proteins to detect protein-protein interactions. This system is based on the activity of the yeast transcription factor Acel (59) , also known as Cup2 (61 reference 29) . The ACEI gene product is composed of two domains acting independently of each other: the N-terminal half specifically binds to DNA in the presence of metal ions (24) , whereas the C-terminal half codes for an acid blob-type transactivator function (11, 24) . These observations are the basis for the protein-protein interaction scheme shown in Fig. 2 . As reporters for Acel activity, we used either the P-galactosidase gene from Escherichia coli fused to the CUPI promoter (59) or metallothionein expression, which leads to copper-resistant growth (23) . Copper has no effect on reporter gene transcription in yeast cells that separately express the two domains of Acel. The creation of two hybrid proteins between the Acel domains and two proteins X and Y results in reporter gene expression in the presence of copper if and only if X and Y interact with one another, as this brings the transactivation part of Acel close to the DNA-binding domain and hence its normal site of action (Fig. 2C) .
In this report, we demonstrate that under the conditions described above, the carboxy-terminal half of the CDC25 gene product binds to both Rasl and Ras2 proteins in vivo. As expected from genetic data, Sdc25 sequences can substitute for Cdc25. Furthermore, using an iral-disrupted yeast strain and defined mutations in the RAS2 gene, we were able to show that Cdc25 specifically binds to the catalytically inactive GDP-bound form of Ras2.
MATERIALS AND METHODS
Yeast strains and transformation. Yeast strains used in this study are described in Table 1 . The Bio-Rad gene pulser was used for transformation of yeast cells by electroporation (1) . For verification of correct integration and gene replacement events, polymerase chain reactions (PCRs) were performed with primers flanking the insertion sites. Subsequently, the amplified fragments were analyzed by agarose gel electrophoresis.
Recombinant DNA techniques. Manipulation of DNA was carried out by using standard procedures throughout this study (36) . E. coli MC1061 was used for the construction and propagation of plasmids. Double-stranded DNA was sequenced by the dideoxynucleotide termination method (50), using the Pharmacia T7 sequencing system. Construction of plasmids that express the Ras-Acel(C) fusion. A 393-bp truncated version of the constitutive glyceraldehyde-3-phosphate dehydrogenase promoter (GAPCLp [38] ) was cloned as a 670-bp SalI-EcoRI fragment into pUC19. Subsequently, the synthetic polylinker composed of EcoRI, NsiI, SphI, and BglII sites, 5'-AATTCATGCATG CATGCAGATCT-3' 3'-GTACGTACGTACGTCTAGATT AA-5', was inserted into the EcoRI site of the former plasmid to give pTM2 and, for the reverse linker orientation, pTM2R. The coding sequence for the transactivation domain of Acel, starting at residue 123, was taken as a 968-bp BglII fragment from plasmid pRI3 (59) and cloned in the BglII site of pTM2, yielding pTM3. pTM4 was constructed by cloning the 1,166-bp SalI-SnaBI fragment of pTM3 between the unique BamHI-SalI sites of the 2,um circle-derived expression plasmid pDP34 (38) after filling in the BamHI site with Klenow enzyme (Fig. 3) (6) containing the yeast CYCl gene (coding for iso-1-cytochrome c1), including its termination sequences, followed by the TRP1 gene was inserted between the EcoRI-BamHI sites of pTM8, yielding the yeast integrating plasmid pTM9 (Fig. 3) .
The carboxy-terminal part of the yeast CDC25 gene (CDC25C), including residues 877 to 1588, was amplified as a PCR BglII-NsiI fragment (primers 5'-GGAGATACTGGA GAATfllTAGATCTGTCAAFT and 5'-GCAAATTGTAT GCAlTTTTATCGAA) from yeast genomic DNA and inserted between the unique BglII-NsiI sites of pTM9. pTM9-CDC25C was integrated into the trpl allele of strain TFY2 after XbaI linearization, producing TFY3.
The carboxy-terminal part of the yeast SDC25 gene (SDC25C) from residues 701 to 1251 was cloned analogously by PCR, using primers creating a PvuII site flanking the SDC25 coding sequence. Digestion of the PCR fragment with PvuII and ligation with blunt-ended BglII-EcoRI-digested pTM9 DNA resulted in plasmid pTM9-SDC25C, which was then integrated into the acel-] allele of TFY2 after linearization with NcoI (TFY58).
Cloning of BCYI. The yeast BCY1 gene was cloned by pyranoside hydrolysis at 420 nm, was normalized to cell culture density and expressed as arbitrary units. The activity in control strain TFY7, TFY14, or TFY60 was set to the value of 1.
RESULTS
Validation of the protein-protein interaction system. To validate the protein-protein interaction assay, we analyzed the ability of the regulatory (R) subunit of the yeast cAMPdependent protein kinase, encoded by the gene BCY1 (9, 35, 57, 60) , to form dimers. Since it is known that the formation of a stable R-subunit dimer requires only a segment within the amino terminus (60), we fused the N-terminal half of the R subunit to the Acel DNA-binding domain (plasmid pTM9-BCY1), integrated the DNA into the yeast strain TFY2, and subsequently transformed this strain (TFY13) with the multicopy plasmid pTM4-BCY1, expressing the transactivation domain of Acel fused to the N terminus of the R subunit (strain TFY15; see Materials and Methods).
The induction of lacZ gene transcription by addition of CuS04 iS shown in Fig. 4 . Copper has no effect on 3-galactosidase expression in strain TFY14 carrying the AcelN-R subunit fusion alone. In contrast, strain TFY15 showed a highly copper dependent expression of the reporter gene, resulting in a maximal stimulation of about 14-fold. Coexpression of both fusion proteins also rendered TFY14 highly copper resistant (not shown). As a negative control we used strain TFY20, which expresses the AcelN-R subunit and the Ras2-AcelC fusions. No copper-dependent induction of 13-galactosidase was measured in TFY20. (4) , as an AcelNCdc25C fusion protein. Figure 5A shows the Cu-inducible expression of the lacZ gene in strain TFY5, expressing both the AcelN-Cdc25C and Ras2-AcelC hybrids, and TFY7, which expresses the AcelN-Cdc25C fusion and the transactivation domain of Acel alone. Copper induces lacZ gene expression to a stimulation of about two-to threefold in strain TFY5 compared with TFY7, which suggests that the C terminus of Cdc25 binds directly to the Ras2 protein in vivo. Addition of more than 50 ,uM CuS04 results in reduced lacZ expression due to copper toxicity (see Discussion). To address the specificity of this interaction, we examined the ability of Cdc25 to bind to mutated Ras2 proteins.
Mutations in Ras2 critically affect binding to Cdc25. Figure 6 shows the viability of yeast strains after 3 days of incubation on CuS04-containing minimal plates. At 110 ,uM CuS04, the copper resistance is restricted to cells expressing AcelC hybrids with wild-type Ras2, Ras2A, Ras2"1e-'52 and Ras2 a-22, whereas the Ras2Val-l9 and Ras2AVal19 hybrids did not grow any more. At 200 ,uM CuS04, strain TFY59 (CDC25C-RAS2Ala-22) is still copper resistant, in contrast to all other RAS2 variants analyzed. In summary, copper resistance and 0-galactosidase levels are correlated. To prove that the Cdc25-and Ras2-Acel hybrid proteins retains their biological activity within the nutrient signal transduction pathway, we examined their abilities to complement the temperature-sensitive cdc25-1 mutation. Expression of the Ras2Vall9-AcelC hybrid fully suppresses the growth lesion of cdc25-1 at the nonpermissive temperature of 37°C, whereas Ras2-AcelC does not (data not shown). This finding is in accordance with previous results showing that the activity of dominant activated Ras2Val-19 is independent of an active Cdc25 protein, in contrast to wild-type Ras2 (4, 37, 47) . Additionally, we found that expression of the Ace1N-Cdc25C hybrid under the control of the Acel promoter restores growth of the cdc25-1 mutant at 37°C (not shown).
Taken together, our data clearly demonstrated that in this hybrid-protein interaction system, the C-terminal half of the CDC25 gene product binds much more strongly to the Ras2Mla-2z and Ras21le-l52 proteins than to wild-type Ras2.
We were not able to detect an interaction between Cdc25 and the constitutively activated Ras2 variant Ras2AvaIl9. Binding of Cdc25 to Ras2VaIl9 was weak, particularly with copper resistance used as a reporter. In the Ras2VaIl9 and especially the Ras2AVaIl9 mutants, a higher amount of GTP is complexed to the protein than in wild-type Ras2 (27, 55) . These findings lead us to speculate that the level of phosphorylation of Ras2-bound guanine nucleotides controls binding to Cdc25. In iral-disrupted strains, Ras2 is constitutively active because Ras2 is complexed with GTP, thus remaining in the activated state (54, 55) . We therefore checked for Ras2-Cdc25 interaction in an iral-disrupted strain.
Cdc25 and Ras do not associate in iral-disrupted yeast strains. We disrupted the IRA1 gene by deleting an essential fraction of its coding region showing homology to the C terminus of the mammalian GTPase-activating protein (GAP) (see Materials and Methods). Figure 7A shows The system that we used to determine this specific proteinprotein interaction, outlined in Fig. 2 , is based on the characteristics of the yeast transcription factor Acel. It allows to qualitatively determine binding affinities between two given proteins simply by varying the copper concentration in the medium. Copper induces the binding of Acel to DNA. Fusion proteins with a high affinity to each other give rise to higher levels of reporter gene expression than do low-affinity complexes. The instability of the latter complexes results in lower P-galactosidase activities and in an enhanced sensitivity to copper. A similar approach based on Gal4 has been used by Fields and Song to show interaction between Snfl and Snf4 (22) . Dimerization of the R subunit of the cyclic AMP-dependent protein kinase, an example of a stable and high-affinity protein-protein interaction, was used to validate the approach. The binding affinity of the Cdc25-Ras interaction is considerably lower than that of the R-subunit dimerization, indicated by a reduced ,B-galactosidase activity and an enhanced sensitivity to copper. We conclude from this observation that Cdc25 is weakly bound to Ras. Survival as a reporter is a very stringent and sensitive marker that overestimates the strength of weak interactions. Quantification of growth is difficult. Cells that would grow no more in the presence of a certain amount of copper might find escape routes, e.g., via inducing CUP1 expression (7, 63) . We therefore consider lacZ to be a more accurate reporter. The rather low affinity between Cdc25 and Ras may be due to a high dissociation rate of the protein complex, which is necessary for transient activation of Ras by Cdc25. Our lack of successful coimmunoprecipitation and coelution experiments supports this interpretation. However, we cannot exclude other reasons, which might contribute to the low binding affinity. First, the Acel domain of the hybrid proteins could sterically block parts of the contact sites of Cdc25 and Ras. Second, since Cdc25 is a membrane-bound protein, only a fraction of the AcelN-Cdc25C fusion might enter the nucleus, whereas the rest sticks to the membrane. This can be excluded in the case of Ras2, because the expression of a Ras2-Ace1N hybrid lacking the C-terminal portion of Ras2, including the membrane localization signal Cys-Ile-Ile-Ser, has no influence on Cdc25 binding, indicating that the interaction between these proteins is restricted to the N-terminal 174 residues of Ras2. The mammalian H-Ras protein, which lacks the variable domain of yeast Ras, complements all of the essential yeast Ras functions in a rasl ras2 yeast mutant (15, 33) , which also indicates that the variable domain of Ras is not necessary for an interaction with Cdc25.
Cdc25 functions as a catalyst for GDP-GTP exchange by Ras proteins. In cells carrying the dominantly activated mutations RAS2Val-l9 and RAS2A, the mutated Ras proteins have a reduced rate of GTP hydrolysis, which renders the cells independent of regulation by Cdc25 (4, 37, 47) . In the double mutant Ras2AVall9 a much higher amount of GTP is complexed to the protein than in the single mutant alone (27) . This reflects the enhanced biological potency of Ras2AvaIl9 to bypass the cdc25 lethality (37) . In strains expressing the Ras2Va'-l9-Ace1C protein, we observed a reduced affinity of Cdc25 for Ras2Val19, and the double mutant Ras2AVal-'9 did not interact with Cdc25 at all. In vegetatively growing cells, the equilibrium of bound guanine nucleotides to wild-type Ras is strongly shifted to the GDPcomplexed form (27) . We propose that Cdc25 interacts preferentially with the GDP-bound Ras protein, implying a rapid dissociation of the protein complex after the conformational change of Ras to the GTP-bound form. The structural changes of Ras after release of GDP and binding of a new GTP molecule would therefore be responsible for the different affinity of Cdc25 to Ras proteins. X-ray studies revealed that two regions of the H-Ras protein are the main elements whose conformation change when GTP replaces GDP: the switch I domain, including residues 30 to 38 of loop L2, and the switch II domain, consisting of residues 60 to 76 of loop L4 and the a2 helix downstream of it (5, 40, 44) . After binding of GTP, both loops interact with the -y phosphate of the guanine nucleotide, which induces the conformational change of H-Ras. Both regions are located at the surface of the molecule, as shown by X-ray analysis of the crystal structure. Therefore, they are good candidates for interaction with other proteins (40) . It has been suggested from genetic experiments that the switch I region and parts of the switch II region are possible contact sites with mammalian GAP (reviewed in references 2 and 40). Furthermore, it was hypothesized that the switch II region is one possible recognition site for a putative upstream regulator of H-ras. The coupling of both switch domains by the -y phosphate leads to a model predicting that the putative guanine nucleotide release protein binds to the switch II domain of H-Ras, which leads to the release of GDP by a subsequent binding of GTP, finally inducing changes in the switch I domain, which is now able to interact with GAP and/or other effector molecules (40) . In view of the high structural and functional similarities between the yeast and mammalian Ras proteins, it is very likely that their topological structures are similar and that the conformational transition between GDP-and GTP-bound forms involve the same structural domains (44 (18, 45, 51, 52) . These mutations are located in the highly conserved phosphate-binding loop Li, where they affect their ability to bind guanine nucleotides: in H-RasAsn-l6 the affinity for both GDP and GTP is reduced (51) , whereas H-RasAsn-l7 has a preferential affinity for GDP (18, 52) . The Ras2MAa-22 mutant is not able to convert from the biologically inactive to the active form either because it is locked in the GDP-bound off conformation or because it is impaired in the ability to bind guanine nucleotides at all, resulting in a permanent association with Cdc25 (45) . Since it is extremely unlikely that Ras proteins exist in a guanine nucleotide-free state for an extended time period (28), we favor the first explanation.
The yeast homologs to mammalian GAP are proteins encoded by the IRAI and IRA2 genes. Disruption of the IRAI or IRA2 gene results in an enhanced production of cAMP in response to addition of glucose due to reduced activity of the endogenous Ras GTPase, which in turn results in a significantly increased amount of Ras-GTP (54, 55) . We found that in an iral-disrupted strain, no interaction between Cdc25 and Ras2 as well as Rasl proteins occurs. One interpretation is that Cdc25 does not bind to the GTP-bound form of Ras, in agreement with the Ras2 point mutation analysis. Our data support the suggestion of Tanaka et al. that Iral negatively regulates the activity of both Ras proteins (55) . This view is in contrast to a previous report, which revealed that a ras2 but not a rasl mutation can suppress the phenotype of an iral disruption (54). However, it is possible that the presence of Iral is somehow necessary for the Cdc25-Ras interaction (see below).
Crechet et al. demonstrated recently that the C-terminal portion of the Sdc25 protein enhances the GDP-GTP exchange of Ras2 by acting especially on GDP-bound Ras2 (13) . This finding leads to the suggestion that at least the carboxy-terminal half of Sdc25 (Sdc25C) interacts like Cdc25 with Ras2. Indeed, our results clearly exemplify this proposal. We are able to directly detect binding of Sdc25C to Ras proteins in vivo. However, there is evidence that the full-length Sdc25 protein is not able to undertake the biological function of Cdc25 (14) . Since the SDC25 gene is dispensable for cell growth, it is not known whether Ras2 is really a physiological target for Sdc25 despite its binding and guanine nucleotide exchange capacity.
In summary, our studies have shown that the carboxy terminus of Cdc25, starting at residue 877, interacts directly with the N-terminal 174 residues of the Ras2 protein in vivo. This interaction is restricted to the catalytically inactive GDP-bound form of Ras2. We cannot exclude the possibility that other proteins or protein domains such as Iral are directly involved in the formation or stabilization of the Cdc25-Ras complex. There is accumulating evidence that protein-protein interactions play an important role in the yeast nutrient signal transduction pathway. The ability of dominant-interfering mutations of AC to suppress the heat shock sensitivity of a Ras2Val19 mutant has led to the idea that the mutated AC acts by sequestering Ras2 proteins, either by a direct binding to Ras via the leucine-rich repeats or with participation of other proteins, which combine with AC to form a complex capable of interacting with Ras, such as the cyclase-associated protein (21) .
Engelberg et al. suggested a biochemical link between Cdc25 and AC, since overexpression of Cdc25 relocalizes AC to the plasma membrane in a rasl ras2 bcyl mutant, in which the cyclase activity is found in the soluble fraction (16) . Data obtained with Iral-specific antibodies, which inhibit binding of AC to the plasma membrane and comigration of Iral and AC in gel filtration chromatography on Sepharose 4B, indicated that both proteins are associated in an oligomeric complex (41) . This complex might also include Ira2 and at least transiently Ras proteins. We suggest that there exists a large multienzyme complex located at the inner surface of the plasma membrane, composed at least of the proteins Cdc25, Rasl, and Ras2, their negative regulators Iral and Ira2, Capl, AC, and maybe Sdc25. This functional unit is activated by phosphorylated glucose via a still putative glucose-repressible protein (reviewed in reference 58). Finally, we want to stress the possibility that at least parts of this large protein complex, namely, Cdc25 (43) , Ras (39, 62) , and Cap (17, 20, 25) , could act as branch points between other signal transduction pathways in yeast cells. This protein-protein interaction system reveals a powerful way to probe for such cross-talks.
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